RG
Publications
229
Views
93,676
Downloads
7,357
Supervised works
19
Items per page
1 - 229 of 229
Title Published in Access level OA Policy Year Views Downloads
Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in RatsMolecular Pharmaceutics
accessLevelRestricted
2020 316 2
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimodEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 334 2
Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone DeliveryOtology & Neurotology
accessLevelRestricted
2019 397 0
Effect of implantation site on outcome of tissue-engineered vascular graftsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 436 1
A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapyInternational journal of pharmaceutics
accessLevelRestricted
2015 905 2
Controlled drug release from melt-extrudates through processing parameters: A chemometric approachInternational journal of pharmaceutics
accessLevelRestricted
2015 659 0
Strategies for formulating and delivering poorly water-soluble drugsJournal of drug delivery science and technology
accessLevelRestricted
2015 844 1
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2015 685 1
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applicationsJournal of chromatography
accessLevelRestricted
2013 665 5
Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2013 688 2
In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular applicationJournal of controlled release
accessLevelRestricted
2013 629 0
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymerJournal of controlled release
accessLevelRestricted
2013 671 1
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2012 711 0
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivativesCarbohydrate Polymers
accessLevelRestricted
2012 457 0
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement modelBiomaterials
accessLevelRestricted
2012 778 0
Advantages of bilayered vascular grafts for surgical applicability and tissue regenerationActa biomaterialia
accessLevelRestricted
2012 718 0
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defectJournal of biomedical materials research. Part A
accessLevelRestricted
2011 737 0
Novel micelle formulations to increase cutaneous bioavailability of azole antifungalsJournal of controlled release
accessLevelRestricted
2011 643 3
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formationJournal of controlled release
accessLevelRestricted
2010 649 0
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in miceJournal of controlled release
accessLevelRestricted
2010 755 3
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicityInternational Journal of Pharmaceutics
accessLevelRestricted
2010 423 1
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2)International journal of pharmaceutics
accessLevelRestricted
2010 683 0
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?Circulation
accessLevelRestricted
2009 653 1
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eyeInvestigative ophthalmology & visual science
accessLevelRestricted
2009 608 0
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritisJournal of controlled release
accessLevelPrivate
2009 720 0
Novel thermosensitive chitosan hydrogels: in vivo evaluationJournal of biomedical materials research. Part A
accessLevelRestricted
2009 697 3
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancerJournal of Drug Targeting
accessLevelRestricted
2009 447 0
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systemsJournal of controlled release
accessLevelRestricted
2009 640 0
A high throughput protein formulation platform: case study of salmon calcitoninPharmaceutical research
accessLevelPublic
2009 654 646
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular graftsJournal of biomedical materials research. Part A
accessLevelPrivate
2009 588 0
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2009 676 0
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle sizeEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 662 0
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective modelNanomedicine
accessLevelPrivate
2009 654 0
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activityJournal of Drug Targeting
accessLevelRestricted
2009 415 1
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cellsEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 607 0
A novel thermoresponsive hydrogel based on chitosanEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 747 1
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compoundDrug development and industrial pharmacy
2008 613 0
High throughput methods to characterize protein permeation and releaseInternational journal of pharmaceutics
accessLevelRestricted
2008 845 3
Colloidal Drug Delivery Systems - Recent Advances With Polymeric MicellesChimia
accessLevelRestricted
2008 935 38
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cellsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2008 519 1
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcomeEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 697 1
A biodegradable drug delivery system for the treatment of postoperative inflammationInternational journal of pharmaceutics
accessLevelRestricted
2008 531 1
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucomaInvestigative ophthalmology & visual science
accessLevelRestricted
2008 695 0
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivativesAntimicrobial agents and chemotherapy
accessLevelRestricted
2008 762 0
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervixJournal of pharmaceutical sciences
accessLevelRestricted
2008 655 0
Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA : PEO Diblock and Triblock CopolymersJournal of drug targeting
accessLevelRestricted
2008 49 0
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulationCirculation
accessLevelRestricted
2008 656 0
Nanoparticles for drug delivery : the need for precision in reporting particle size parametersEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 691 2
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2007 660 0
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugationInternational journal of pharmaceutics
accessLevelRestricted
2007 705 7
Biological conversion of a water-soluble prodrug of cyclosporine AEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 647 8
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymesBioconjugate chemistry
accessLevelRestricted
2007 654 0
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systemsJournal of biomedical materials research. Part A
accessLevelRestricted
2007 677 2
Polymeric photosensitizer prodrugs for photodynamic therapyPhotochemistry and photobiology
accessLevelPrivate
2007 662 0
NIR analysis of cellulose and lactose—Application to ecstasy tablet analysisForensic science international
accessLevelRestricted
2007 943 1
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systemsAdvanced drug delivery reviews
accessLevelRestricted
2007 674 2
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degenerationInvestigative ophthalmology & visual science
accessLevelRestricted
2007 544 0
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagusJournal of controlled release
accessLevelPrivate
2007 684 0
Characterization of protein aggregation: the case of a therapeutic immunoglobulinBiochimica et biophysica acta
accessLevelRestricted
2007 643 0
Detection and characterization of protein aggregates by fluorescence microscopyInternational journal of pharmaceutics
accessLevelRestricted
2007 649 0
High throughput screening of protein formulation stability: practical considerationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 652 0
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in ratsMolecular vision
accessLevelPublic
2006 79 119
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coatingAAPS PharmSciTech
accessLevelPublic
2006 583 214
Biodegradable nanoparticles for direct or two-step tumor immunotargetingBioconjugate chemistry
accessLevelRestricted
2006 509 0
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structuresBiomaterials
accessLevelRestricted
2006 514 1
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancerInternational journal of pharmaceutics
accessLevelRestricted
2006 554 1
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)International journal of pharmaceutics
accessLevelRestricted
2006 570 4
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: An EPR imaging studyJournal of controlled release
accessLevelRestricted
2006 185 0
An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical AdministrationDrugs in R&D
accessLevelPublic
2006 127 115
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pHInternational journal of pharmaceutics
accessLevelRestricted
2006 533 1
Intraocular implants for extended drug delivery: therapeutic applicationsAdvanced drug delivery reviews
accessLevelRestricted
2006 631 1
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregatesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2006 384 1
Biodegradable scleral implants as new triamcinolone acetonide delivery systemsInternational journal of pharmaceutics
accessLevelRestricted
2006 490 1
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and PerspectivesPhotochemistry and photobiology
accessLevelRestricted
2006 94 0
In vitro and in vivo activities of verteporfin-loaded nanoparticlesJournal of Controlled Release
accessLevelRestricted
2005 184 0
Coupling Methods to Obtain Ligand-Targeted Liposomes and NanoparticlesMicroencapsulation : methods and industrial applications
accessLevelRestricted
2005 67 0
Conversion of cyclosporine A prodrugs in human tears vs rabbits tearsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2005 469 0
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the EyeChimia
accessLevelRestricted
2005 461 0
A water-soluble prodrug of cyclosporine A for ocular application: A stability studyEuropean journal of pharmaceutical sciences
accessLevelPublic
2005 829 701
Trans-scleral diffusion of triamcinolone acetonideCurrent eye research
accessLevelRestricted
2005 545 1
The use of drug-loaded nanoparticles in cancer chemotherapyMicroencapsulation : Methods and Industrial Applications
accessLevelRestricted
2005 62 0
Pseudo-thermosetting chitosan hydrogels for biomedical applicationInternational journal of pharmaceutics
accessLevelRestricted
2005 546 1
Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in GenevaChimia
2005 393 0
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kineticsInternational journal of pharmaceutics
accessLevelRestricted
2005 540 1
Synthesis and Ring-Opening Polymerization of New Monoalkyl-Substituted LactidesJournal of polymer science. Part A, Polymer chemistry
accessLevelRestricted
2004 256 0
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryosInternational journal of pharmaceutics
accessLevelRestricted
2004 518 1
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performanceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 552 0
New surface-active polymers for ophthalmic formulations: evaluation of ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 498 3
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 581 1
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targetingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 445 4
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 532 1
Current Methods for Attaching Targeting Ligands to Liposomes and NanoparticlesJournal of Pharmaceutical Sciences
accessLevelRestricted
2004 171 0
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradationJournal of biomedical materials research. Part A
accessLevelRestricted
2003 191 0
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticlesInvestigative Ophthalmology & Visual Science
accessLevelPublic
2003 477 210
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapyEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 653 0
Bioadhesive Ophthalmic Drug Inserts (BODI)Modified-release drug delivery technology
accessLevelPublic
2003 104 156
In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance ImagingMacromolecules
accessLevelRestricted
2003 773 0
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologiesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 474 1
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic ActivityPhotochemistry and photobiology
accessLevelRestricted
2003 72 0
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humansAAPS PharmSci
accessLevelRestricted
2002 572 0
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine deliveryJournal of controlled release
accessLevelRestricted
2002 518 0
Ocular tolerance of absorption enhancers in ophthalmic preparationsAAPS PharmSci
accessLevelRestricted
2002 456 1
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2002 470 2
State of the art in the delivery of photosensitizers for photodynamic therapyJournal of photochemistry and photobiology. B, Biology
accessLevelRestricted
2002 69 0
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eyeInvestigative ophthalmology and visual science
accessLevelPublic
2002 200 137
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicleAAPS PharmSci
accessLevelRestricted
2001 502 0
Therapeutic applications of viscous and injectable poly(ortho esters)Advanced drug delivery reviews
accessLevelRestricted
2001 515 1
Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded NanoparticlesPharmaceutical research
accessLevelPublic
2001 56 137
Fluorescence correlation spectroscopy for the characterisation of drug delivery systemsBiological chemistry
accessLevelRestricted
2001 493 0
Challenges of Intraocular Drug DeliveryEuropean pharmaceutical review
accessLevelPublic
2001 109 18
Influence of hot-melt extrusion and compression molding on polymer structure organization, investigated by differential scanning calorimetryJournal of Applied Polymer Science
accessLevelRestricted
2001 358 0
Release of BSA from poly(ortho ester) extruded thin strandsJournal of Controlled Release
accessLevelRestricted
2001 261 0
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgeryInvestigative Ophthalmology & Visual Science
accessLevelPublic
2001 310 118
Treatment of Intralocular Diseases with Poly(ortho ester)-Based Drug Delivery SystemsMacromolecular symposia
accessLevelRestricted
2001 113 0
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogsAAPS PharmSci
accessLevelRestricted
2001 544 0
Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInternational journal of pharmaceutics
accessLevelRestricted
2001 471 1
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocketBiomaterials
accessLevelRestricted
2001 471 1
Protein Release from Poly(ortho ester) Extruded RodsMacromolecular symposia
accessLevelRestricted
2001 83 0
Development of poly(ortho esters)Drug delivery systems & sciences
accessLevelRestricted
2001 408 1
Polymeric systems for ophthalmic drug deliveryPolymeric Biomaterials
accessLevelRestricted
2001 64 0
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particlesInternational journal of pharmaceutics
accessLevelRestricted
2001 543 1
Poly(ortho esters) - A Versatile Drug Delivery SystemBiomaterials and Drug Delivery toward New Mellenium
accessLevelRestricted
2000 429 0
Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle TechnologyPharmaceutical research
accessLevelPublic
2000 71 178
Poly (ortho esters) implants for the sustained delivery of a protein factors influencing the release behaviour of BSA in vitroThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 55 85
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateJournal of controlled release
accessLevelRestricted
2000 195 0
Poly(ortho esters) - their development and some recent applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 542 1
Local delivery of antimicrobial agents for the treatment of periodontal diseasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 438 1
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradationBiomaterials
accessLevelRestricted
2000 552 2
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro releaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 665 0
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactantsInternational journal of pharmaceutics
accessLevelRestricted
2000 453 1
A novel analytical approach for the characterization of poly(MePegcyanoacrylate - co - hexadecylcyanoacrylate) nanoparticlesThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 53 46
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer NanoparticlesPharmaceutical development and technology
accessLevelRestricted
2000 75 0
Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial EfficacyJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
2000 123 0
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinsesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 495 1
Formation of peptide impurities in polyester matrices during implant manufacturingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 604 0
Formulation and technology aspects of conrolled drug delivery in animalsPharmaceutical science & technology today
accessLevelRestricted
2000 87 0
Design and development of controlled release veterinary drug delivery systems to the eyeControlled Release Veterinary Drug Delivery
accessLevelRestricted
2000 140 0
Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimizationCRS proceedings
accessLevelPublic
1999 230 59
Production of biodegradable implants for the sustained release of pharmaceuticalsAsian Conference and Exhibition of Controlled Release
accessLevelRestricted
1999 423 1
Evaluation of the local and systemic inflammatory responses induced by the subcutaneous injection of different biopolymersCRS proceedings
accessLevelPublic
1999 51 46
Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymersCRS proceedings
accessLevelPublic
1999 57 33
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retentionInternational journal of pharmaceutics
accessLevelRestricted
1999 525 1
Hydrolysis and Erosion Studies of Autocatalyzed Poly(ortho esters) Containing Lactoyl−Lactyl Acid DimersMacromolecules
accessLevelRestricted
1999 166 0
How to avoid the formation of peptide impurities during manufacturing of implants by melt-extrusion ?CRS proceedings
accessLevelPublic
1999 54 50
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular applicationJournal of biomedical materials research
accessLevelPublic
1999 172 201
Erosion, properties and drug release from a new family of poly(ortho esters)Proceedings of the 26th International Symposium on Controlled Release of Bioactive Materials and the Second Conference on Consumer and Diversified Products
accessLevelPublic
1999 45 18
Poly(ortho esters)Encyclopedia of controlled drug delivery
accessLevelRestricted
1999 114 0
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell UptakePharmaceutical research
accessLevelPublic
1999 46 138
Biodegradable implantsAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 397 56
Evaluation of poly(ortho ester) for intraocular application in rabbits: biocompatibility assessment and in vitro degradationCRS proceedings
accessLevelPublic
1999 65 126
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complexEuropean journal of pharmaceutical sciences
accessLevelRestricted
1999 516 0
Poly(ortho ester): a new biocompatible intraocular drug delivery systemAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 86 22
Ocular tolerance of preservatives on the murine corneaEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 423 1
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactateJournal of biomaterials science. Polymer ed
accessLevelRestricted
1999 144 0
Stability studies of a somatostatin analogue in biodegradable implantsInternational journal of pharmaceutics
accessLevelRestricted
1999 445 1
Mucosal drug delivery, ocularEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 149 0
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implantsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 553 3
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localizationEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 461 2
Mucosal drug delivery, intravitrealEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 156 0
Gamma scintigraphy as tool for the evaluation of precorneal residence time: influence of the methodologyCRS proceedings
accessLevelPublic
1999 49 56
NanoparticlesEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 207 0
Protein delivery from extruded poly(ortho esters)Asian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 399 52
Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systemsCRS proceedings
accessLevelPublic
1999 53 92
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1999 589 0
Synthesis and characterization of self-catalyzed poly(ortho ester)Biomaterials
accessLevelRestricted
1998 630 0
Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 520 2
Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 311 1
pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 524 1
In vitro drug release from self-catalyzed poly(ortho ester): Case study of 5-fluorouracilJournal of controlled release
accessLevelRestricted
1998 196 0
Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 631 1
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental cariesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1998 484 1
Biodegradable polymers for the controlled release of ocular drugsProgress in polymer science
accessLevelRestricted
1998 60 0
Chitosan: a unique polysaccharide for drug deliveryDrug development and industrial pharmacy
accessLevelRestricted
1998 562 0
A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 468 1
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infectionsJournal of controlled release
accessLevelRestricted
1998 661 0
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 435 1
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogueJournal of controlled release
accessLevelRestricted
1998 221 0
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimeticsAdvanced drug delivery reviews
accessLevelRestricted
1998 455 0
Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 450 1
Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular ToleranceJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1998 137 0
Bioerodible Polymers for Ocular Drug DeliveryCritical reviews in therapeutic drug carrier systems
accessLevelRestricted
1998 155 0
Influence of irradiation sterilization on a semi-solid poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1998 562 0
Therapeutic applications of retinoids in ophthalmologyInternational journal of pharmaceutics
accessLevelRestricted
1997 439 2
Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug releaseInternational journal of pharmaceutics
accessLevelRestricted
1997 514 1
Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogueEuropean journal of pharmaceutical sciences
accessLevelRestricted
1997 482 0
Prophylaxis of caries : in vivo evaluation of various oral fluoride containing preparations designed to optimize salivary concentrationsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelRestricted
1997 68 0
Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A ReviewDrug development and industrial pharmacy
accessLevelRestricted
1997 567 1
Determination of dexamethasone in tears by capillary electrophoresisJournal of chromatography. B, Biomedical sciences and applications
1997 520 0
Confocal Microscopy as a Tool for the Investigation of the Anterior Part of the EyeJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1997 126 0
Ocular drug delivery in veterinary medicineAdvanced drug delivery reviews
accessLevelRestricted
1997 538 0
PLA-PEG nanoparticles: preparation and cell interaction studiesProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 45 39
In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral useEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 448 1
Synthesis and characterization of ointment-like self-catalyzed poly(ortho ester)Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 52 193
New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibilityJournal of controlled release
accessLevelRestricted
1997 278 0
Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axisEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 204 0
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulationsPharmaceutica Acta Helvetiae
accessLevelRestricted
1997 52 0
Combined release of dexamethasone and gentamicin from an ocular insert for treatment of external ophthalmic infectionsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 88 116
Development of a long-term delivery system for RC-160, a somatostatin analogProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 50 37
Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localizationProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 104 98
Improved biocompatibility of a viscous bioerodable poly(orthoester) by controlling the environmental pHProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 43 131
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvementJournal of biomedical materials research
accessLevelRestricted
1997 122 0
Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticlesActa pharmaceutica
accessLevelPublic
1996 408 111
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogsPharmaceutical research
accessLevelPublic
1996 47 44
Basis for Dosing Time-Dependent Changes in the Ocular and Systemic Absorption of Topically Applied TimololJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 132 0
Development of a Novel Soluble Ophthalmic Insert: Evaluation of Ocular Tolerance in RabbitsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 196 67
Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy VolunteersJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 115 0
Biomaterials in Ophthalmic Drug DeliveryEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 525 97
The Use of Drug-Loaded Nanoparticles in Cancer ChemotherapyMicroencapsulation : methods and industrial applications
accessLevelRestricted
1996 51 0
Mucoadhesive Semi-Solid Formulations for Intraoral Use Containing SucralfateEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 311 180
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug deliveryJournal of controlled release
accessLevelRestricted
1996 91 0
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systemsBiomaterials
accessLevelRestricted
1996 513 2
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insertPharmaceutical research
accessLevelPublic
1995 56 324
Patent Literature Review of Ophthalmic InsertsDrug development and industrial pharmacy
accessLevelRestricted
1995 535 2
The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester)Journal of controlled release
accessLevelRestricted
1995 87 0
Use of Insoluble Biodegradable Polymers in Ophthalmic Systems for the Sustained Release of DrugsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 311 216
Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigationJournal of controlled release
accessLevelRestricted
1995 50 0
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogelsAdvanced drug delivery reviews
accessLevelRestricted
1995 647 0
New Approach for the Preparation of Nanoparticles by an Emulsification-Diffusion MethodEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 680 1,445
PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary TumoursJournal of Pharmacy and Pharmacology
accessLevelRestricted
1995 152 0
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife sciences
accessLevelRestricted
1995 153 1
Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to MiceJournal of Pharmaceutical Sciences
accessLevelRestricted
1995 120 0
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery: validation and radiation effectsPharmaceutical research
accessLevelPublic
1994 127 224
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymersJournal of biomaterials science. Polymer ed
accessLevelRestricted
1994 183 0
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracilJournal of biomedical materials research
accessLevelRestricted
1994 159 0
Application of Medical Imaging to Pharmaceutical Research: the Example of Gamma Scintigraphy. I: Technological AspectsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1994 197 26
Long-term histopathological study of new polypeptidic biomaterialsBiomaterials
accessLevelRestricted
1992 536 2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle sizeInternational journal of pharmaceutics
accessLevelRestricted
1992 683 2
Aqueous nanodispersions prepared by a salting-out processInternational journal of pharmaceutics
accessLevelRestricted
1992 625 1
Du fard des Egyptiens aux pseudo-latex : évolution des formes médicamenteuses en ophtalmologieCahiers de la Faculté des sciences / Université de Genève
accessLevelPublic
1982 7 13
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack